---
title: "CITIC Securities: Optimistic about domestic cosmetics based on organizational evolution, product enhancement, and marketing operation advantages to increase market share"
description: "CITIC Securities is optimistic about the market prospects of domestic cosmetics, believing that the operational fluctuations of international brands in China provide growth space for domestic products"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261952442.md"
published_at: "2025-10-21T00:11:30.000Z"
---

# CITIC Securities: Optimistic about domestic cosmetics based on organizational evolution, product enhancement, and marketing operation advantages to increase market share

> CITIC Securities is optimistic about the market prospects of domestic cosmetics, believing that the operational fluctuations of international brands in China provide growth space for domestic products, especially in the high-end beauty care sector. The operational differentiation of international brands indicates that the beauty care industry requires support from multidimensional comprehensive capabilities. Based on organizational evolution, product enhancement, and marketing operation advantages, domestic cosmetics are expected to increase market share. The rating for the beauty industry is maintained at "outperforming the market."

CITIC Securities pointed out that, based on the selected sample of international beauty and personal care listed companies, the beauty and personal care industry operates with fluctuations on a global scale, and the performance of international brands has shown divergence. Focusing on the China region, almost only L'Oréal has achieved sustained sales growth, while some companies have optimized their operating models after strategic restructuring, but their sales momentum has yet to recover, and some international companies continue to face operational pressure. From a short-term perspective, the operational fluctuations of international brands in the China region provide better growth space for domestic products, especially in the high-end beauty and personal care sector where domestic brands have less presence. In the medium term, the operational fluctuations and divergence of international beauty and personal care companies further illustrate that the beauty and personal care industry requires multi-dimensional comprehensive capabilities in organization, products, channels, and marketing to support growth. Against this backdrop, we remain optimistic about domestic cosmetics increasing market share based on organizational evolution, product enhancement, and marketing operational advantages. We maintain an "outperform the market" rating for the beauty and personal care industry

### Related Stocks

- [LRLCY.US - L'Oréal S.A.](https://longbridge.com/en/quote/LRLCY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| L'Oreal CEO: Not happy with skincare, we outpaced market for 8 years but not in 2025 | L'Oreal CEO: Not happy with skincare, we outpaced market for 8 years but not in 2025 | [Link](https://longbridge.com/en/news/275883512.md) |
| L'Oreal's Shares Drop After Soft End to the Year | L'Oreal's shares fell 4.5% to 374.10 euros after the company reported weaker-than-expected fourth-quarter results, with  | [Link](https://longbridge.com/en/news/275881106.md) |
| AI disruption overblown but not yet time to buy - Jefferies  | Jefferies economist Mohit Kumar believes fears surrounding AI disruption are overblown, but advises against buying into  | [Link](https://longbridge.com/en/news/275889165.md) |
| J.P. Morgan Sticks to Its Hold Rating for L’Oreal (0NZM) | J.P. Morgan analyst Celine Pannuti maintained a Hold rating on L’Oreal with a price target of €365.00. Pannuti has an av | [Link](https://longbridge.com/en/news/276477719.md) |
| RBC Capital Reaffirms Their Buy Rating on L’Oreal (0NZM) | RBC Capital has reaffirmed its Buy rating on L’Oreal (0NZM) with a price target of €410.00, according to analyst Wassach | [Link](https://longbridge.com/en/news/275811927.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
